Research Study of T Cell Immunotherapy Continues to Show Highly Promising Results in Children and Ad
Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient's immune system.
Read more here: http://www.sacbee.com/2013/12/07/5979130/research-study-of-t-cell-immunotherapy.html#storylink=cpy